Cited by 21Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and TreatmentThyroid and Parathyroid Surgery

A low incidence of iodine‐induced hyperthyroidism following administration of iodinated contrast in an iodine‐deficient region

Open access
Jarvis, Carol, Simcox, Kim, Tamatea, Jade A. U., McAnulty, Kim, Meyer‐Rochow, Goswin Y., Conaglen, John V., Elston, Marianne S.·2016·Clinical Endocrinology

Abstract

Summary: Objective: There are limited data on the incidence of iodinated contrast‐induced thyrotoxicosis, particularly in iodine‐deficient regions. The aim of this study was to determine the incidence of iodinated contrast‐induced thyrotoxicosis and to determine whether thyrotoxicosis was more common in patients ≥70 years compared to those <70 years of age. Design: A prospective study of adult patients undergoing an outpatient CT with iodinated contrast was performed. Measurements: Thyroid function tests (TFT s) and urine iodine measurements were performed prior to the scan. TFT s were repeated at 4‐ and 8‐weeks postscan. Changes in TFT s from baseline were analysed. Results: A total of 102 patients were included in the final analysis. Overall, TSH levels dropped (P = 0·0002), and free T 3 (FT3) levels increased (P = 0·04) between baseline and week 4 with normalization by week 8; however, these changes were not considered clinically significant. No significant differences in free T 4 (FT4) occurred in the overall group (P = 0·82). There were no differences in TFT s between baseline and 4 or 8 weeks for those patients aged <70 compared to ≥70 years. Two patients developed new subnormal TSH values. Of these, one had a 90‐mm follicular variant papillary thyroid carcinoma diagnosed while the other had a normal thyroid assessment and TSH spontaneously normalized by 12 weeks. Conclusions: Only 2% of patients developed subclinical hyperthyroidism following a standard dose of iodinated contrast for CT investigations. Given the low incidence of iodine‐induced thyrotoxicosis, there is no indication for routine pre‐ and post‐CT thyroid function testing in our region.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cen.12818

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. ThomsonCD, Colls AJ, Conaglen JV et al. (1997) British Journal of Nutrition, 78, 901-912.
  2. World Health Organization. (2007) Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers. 3rd edition, Geneva, World Health Organization

Cited by

Sorted by citations

Authors
Jarvis, C., Simcox, K., Tamatea, J. A. U., McAnulty, K., Meyer‐Rochow, G. Y., Conaglen, J. V., & Elston, M. S.
Affiliations
  • Waikato Hospital (NZ)
  • Department of Surgery Waikato Hospital Hamilton New Zealand
  • University of Auckland (NZ)
Corresponding author
Elston, Marianne S.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2015-06-19
Volume
84
Issue
4
Pages
558-563
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W1847388526
Cited by
21
References
23
Citations by year
2026: 1 · 2025: 1 · 2024: 5 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 1 · 2016: 2 · 2015: 1 · 2014: 1
FWCI
1.16
Type
journal article
Language
en
Open access
Locations
  • Clinical Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • ResearchSpace (University of Auckland) (submittedVersion)
Funders
Waikato Medical Research Foundation (208)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
Keywords
iodinated contrast media, iodine deficiency, subclinical hyperthyroidism, computed tomography, thyroid function tests, thyroid-stimulating hormone, free T3, free thyroxine, elderly patients, iodine supplementation, follicular variant of papillary thyroid carcinoma
MeSH terms
Adult, Aged, Aged, 80 and over, Contrast Media, Female, Humans, Hyperthyroidism, Iodine, Male, Middle Aged, New Zealand, Outpatients, Prospective Studies, Thyroid Function Tests, Thyrotropin, Thyroxine, Time Factors, Tomography, X-Ray Computed, Triiodothyronine, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review